Shida A - Search Results

1

Comparison of Short-term and Long-term Clinical Outcomes Between Laparoscopic and Open Total Gastrectomy for Patients With Gastric Cancer.

Shida A, Mitsumori N, Fujioka S, Takano Y, Iwasaki T, Takahashi N, Ishibashi Y, Omura N, Yanaga K. Shida A, et al. Surg Laparosc Endosc Percutan Tech. 2016 Aug;26(4):319-23. doi: 10.1097/SLE.0000000000000285. Surg Laparosc Endosc Percutan Tech. 2016. PMID: 27438173 Free PMC article.

2

Pre-pyloric site gastric cancer after pylorus-preserving gastrectomy (PPG): a case report.

Shida A, Fujioka S, Kobayashi K, Ishibashi Y, Omura N, Mitsumori N, Ohmura M, Yanaga K. Shida A, et al. Int J Surg. 2008 Dec;6(6):e20-3. doi: 10.1016/j.ijsu.2006.09.009. Epub 2006 Nov 13. Int J Surg. 2008. PMID: 19059127 Free article.

3

Prediction of lymph node metastasis in patients with submucosa-invading early gastric cancer.

Shida A, Fujioka S, Kawamura M, Takahashi N, Ishibashi Y, Nakada K, Mitsumori N, Omura N, Yanaga K. Shida A, et al. Anticancer Res. 2014 Aug;34(8):4471-4. Anticancer Res. 2014. PMID: 25075087

4

Prediction of lymph node metastasis and sentinel node navigation surgery for patients with early-stage gastric cancer.

Shida A, Mitsumori N, Nimura H, Takano Y, Iwasaki T, Fujisaki M, Takahashi N, Yanaga K. Shida A, et al. World J Gastroenterol. 2016 Sep 7;22(33):7431-9. doi: 10.3748/wjg.v22.i33.7431. World J Gastroenterol. 2016. PMID: 27672266 Free PMC article. Review.

5

Prognostic significance of vascular endothelial growth factor D in gastric carcinoma.

Shida A, Fujioka S, Ishibashi Y, Kobayashi K, Nimura H, Mitsumori N, Suzuki Y, Kawakami M, Urashima M, Yanaga K. Shida A, et al. World J Surg. 2005 Dec;29(12):1600-7. doi: 10.1007/s00268-005-0076-z. World J Surg. 2005. PMID: 16311850

6

Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma.

Shida A, Fujioka S, Kobayashi K, Ishibashi Y, Nimura H, Mitsumori N, Yanaga K. Shida A, et al. Int J Clin Oncol. 2006 Feb;11(1):38-43. doi: 10.1007/s10147-005-0528-3. Int J Clin Oncol. 2006. PMID: 16508727

7

Clinical significance of Rho GDP dissociation inhibitor 2 in colorectal carcinoma.

Fujita A, Shida A, Fujioka S, Kurihara H, Okamoto T, Yanaga K. Fujita A, et al. Among authors: shida a. Int J Clin Oncol. 2012 Apr;17(2):137-42. doi: 10.1007/s10147-011-0270-y. Epub 2011 Jun 24. Int J Clin Oncol. 2012. PMID: 21698524

8

Preoperative determination of appropriate cutting line for proximal gastrectomy to avoid postoperative jejunal ulcer.

Takahashi N, Kashimura H, Nimura H, Watanabe A, Yano K, Aoki H, Koyama T, Sasaki T, Shida A, Mitsumori N, Aoki T, Kashiwagi H, Yanaga K. Takahashi N, et al. Among authors: shida a. Hepatogastroenterology. 2012 Jul-Aug;59(117):1478-9. doi: 10.5754/hge10063. Hepatogastroenterology. 2012. PMID: 22683965

9

Reduced expression of Rho GDP dissociation inhibitor 2 mRNA is associated with lymph node metastasis in gastric carcinoma.

Shida A, Fujioka S, Takahashi N, Aoki H, Okamoto T, Mitsumori N, Omura N, Yanaga K. Shida A, et al. Oncol Lett. 2013 Aug;6(2):463-467. doi: 10.3892/ol.2013.1379. Epub 2013 Jun 6. Oncol Lett. 2013. PMID: 24137348 Free PMC article.

10

Sentinel lymph node navigation surgery for early stage gastric cancer.

Mitsumori N, Nimura H, Takahashi N, Kawamura M, Aoki H, Shida A, Omura N, Yanaga K. Mitsumori N, et al. Among authors: shida a. World J Gastroenterol. 2014 May 21;20(19):5685-93. doi: 10.3748/wjg.v20.i19.5685. World J Gastroenterol. 2014. PMID: 24914329 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters